Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Cahill

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Neuro-Oncology|October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsJulie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
JCO Precision Oncology|September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent GlioblastomaAndrew S Chi, Daniel P Cahill, David A Reardon, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
JAMA Oncology|July 17, 2015
Rapid Intraoperative Molecular Characterization of GliomaGanesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Science (New York, N.Y.)|April 1, 2017
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seqAndrew S Venteicher, Itay Tirosh, Christine Hebert, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2023
Intraoperative Integrated Diagnostic System for Malignant Central Nervous System TumorsTakahiro Hayashi, Kensuke Tateishi, Shinichiro Matsuyama, et al.
Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.
Acta Neuropathologica|August 21, 2018
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcomeTareq A Juratli, Devin McCabe, Naema Nayyar, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Neuro-Oncology|October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsJulie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
JCO Precision Oncology|September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent GlioblastomaAndrew S Chi, Daniel P Cahill, David A Reardon, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
JAMA Oncology|July 17, 2015
Rapid Intraoperative Molecular Characterization of GliomaGanesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Science (New York, N.Y.)|April 1, 2017
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seqAndrew S Venteicher, Itay Tirosh, Christine Hebert, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2023
Intraoperative Integrated Diagnostic System for Malignant Central Nervous System TumorsTakahiro Hayashi, Kensuke Tateishi, Shinichiro Matsuyama, et al.
Nature Medicine|May 4, 2021
Evolution of delayed resistance to immunotherapy in a melanoma responderDavid Liu, Jia-Ren Lin, Emily J Robitschek, et al.
Acta Neuropathologica|August 21, 2018
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcomeTareq A Juratli, Devin McCabe, Naema Nayyar, et al.
Pageof 20